AstriVax jobs and careers
Heverlee, Flemish Region, Belgium
About AstriVax
AstriVax is a privately held spin-off company from the KU Leuven, founded in 2022 based on vaccine technology developed at the Rega Institute. AstriVax is building a first in class Plug & Play vaccine platform with a patented DNA based technology that launches self-amplifying live attenuated viruses. The versatile technology of AstriVax can be used to develop a wide range of vaccines to prevent and treat infectious diseases. AstriVax aims to address major challenges in vaccinology by developing novel vaccines that are easy to produce, have reduced cold chain requirements, and offer broad and long-lasting protection against various viruses and other pathogens.
- Employees
- 1 to 10
- Headquarters
- Heverlee
Leadership
The top of AstriVax's org chart, with how many people report into each leader.
Hanne Callewaert
Chief Executive Officer
15 reports
Wilfried Dalemans
Chief Technical Officer (ad Interim)
6 reports
Sophie Olivier
CMO a.i.
2 reports
Mathieu Peeters
Chief Development Officer (CDO)
1 report
An Huysmans
Finance Lead
Isabelle Decoster
HR Lead
Greg Fanning
Chief Business Officer
Board
Peter Piot
Scientific Advisory Board Member
Shelley Margetson
Board Member
Jeroen Vangindertael
Board Observer
Christian Brander
Scientific Advisory Board Member
Bart De Taeye
Board Member
Jeanne Bolger
Chairman & Independent Board Member
Jobs at AstriVax
No open positions right now. Explore more companies on TheJobsMap.